Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 41 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1997Effects of gemfribozil and clofibric acid on the uptake of taurocholate by isolated rat hepatocytesSabordo, L.; Sallustio, B.
2004Optimisation of the comet genotoxicity assay in freshly isolated murine hepatocytes: detection of strong in vitro DNA damaging properties for styreneFontaine, F.; DeGraaf, Y.; Ghaoui, R.; Sallustio, B.; Edwards, J.; Burcham, P.
2005Evaluation of the immunotech cyclosporine direct radioimmunoassay for the determination of whole-blood cyclosporine in renal transplant patientsWesley, I.; Sallustio, B.; Morris, R.
1999Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.Sallustio, B.; Morris, R.
2011Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samplesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2003UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytesGhaoui, R.; Sallustio, B.; Burcham, P.; Fontaine, F.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2002Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state doseSallustio, B.; Westley, I.; Morris, R.
1998Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine serviceMorris, R.; Black, A.; Harris, A.; Batty, A.; Sallustio, B.
2006Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatographyDavies, B.; Herbert, M.; Culbert, J.; Pyke, S.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.